AMES, Iowa, Aug. 14 /PRNewswire-FirstCall/ -- BioForce Nanosciences
(OTC Bulletin Board: BFNH) has announced a new brand name for the company's
core technology to complement and coincide with the target placement of
twenty customer units in 2006. BioForce has placed five units with
customers, with another five installations scheduled for the third quarter
and is on track to meet its target, the company said.
BioForce has developed a benchtop molecular printing system that places
tiny domains of biological materials on surfaces with nanometer spatial
precision. Previously called the NanoArrayer, it now will be known as the
"The Nano eNabler brand name is an excellent description of the
capabilities our benchtop molecular printing technology provides our
customers," said Michael Lynch, product manager. "The feedback we have
received from our clients makes this transition to a new brand name an easy
decision. Our clients are using the BioForce technology to enable biosensor
printing, stem cell studies and tissue engineering, to name a few uses."
"This rebranding effort complements our continued plan to develop 20
Nano eNabler customer sites this year," said Kerry Frey, chief operations
officer. "I am very pleased that we are on track to meet this placement
goal by the end of 2006."
"BioForce identifies and qualifies each new technology evaluation site
to provide the company with valuable third party feedback on the Nano
eNabler performance," said Eric Henderson, founder and chief executive
officer. "Information on the value of the Nano eNabler brand for these
emerging bionanotechnology applications is important to BioForce as we
continue to market our technology."
About BioForce Nanosciences, Inc.
BioForce Nanosciences is a nanotechnology tools and applications
company, providing innovative and practical products that support the
growth of the nanotechnology industry. The company has spent more than a
decade of invention, research and development on patented and
patent-pending nanotechnology products. The core technology is the Nano
eNabler(TM) Benchtop Molecular Printer, a portal to new opportunities in
nanotechnology. The Nano eNabler opens the door to new and important
applications in the biomedical and life sciences markets that lead to
improved quality of life. BioForce continues to target inventions that
further expand the reach of its proprietary technology and expand its
robust patent, trademark and IP portfolio.
BioForce Nanosciences, Inc., the Practical Nanotechnology(TM) company
brings inventions to the marketplace that complement existing innovations,
licensing and acquisitions. BioForce is a wholly owned subsidiary of
BioForce Nanosciences Holdings, Inc. (OTC Bulletin Board: BFNH). For more
information, visit www.bioforcenano.com.
This news release contains forward-looking information that may be
affected by certain risks and uncertainties, including those risks and
uncertainties described in the company's most recent filings with the
Securities and Exchange Commission. The company's actual results could
differ materially from such forward-looking statements. We assume no duty
to update these statements at any future date.
SOURCE BioForce Nanosciences